Enrico Pinto
Overview
Explore the profile of Enrico Pinto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
566
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neri A, Megha T, Bettarini F, Tacchini D, Mastrogiulio M, Marrelli D, et al.
Hum Pathol
. 2012 Mar;
43(8):1184-91.
PMID: 22397869
Overexpression of tissue inhibitor of metalloproteinase-1 at either the messenger RNA or protein level has been related to a poorer prognosis in breast cancer. We investigated the role of tissue...
2.
Roviello F, Caruso S, Marrelli D, Pedrazzani C, Neri A, De Stefano A, et al.
Surg Oncol
. 2010 Oct;
20(1):e38-54.
PMID: 20888755
Peritoneal carcinomatosis (PC) had long been regarded as a terminal disease, characterized by a very poor survival and worth treating with palliative therapy. A new strategy combining maximal surgery (cytoreductive...
3.
Roviello F, Pinto E, Corso G, Pedrazzani C, Caruso S, Filippeschi M, et al.
J Surg Oncol
. 2010 Aug;
102(6):663-70.
PMID: 20721959
Objectives: To analyze the outcomes of cytoreductive surgery and HIPEC in patients with peritoneal carcinomatosis from ovarian cancer. Methods: Fifty-three patients with peritoneal carcinomatosis from primary (45 cases) and recurrent...
4.
Pedrazzani C, Cerullo G, de Marco G, Marrelli D, Neri A, De Stefano A, et al.
World J Gastroenterol
. 2009 Dec;
15(45):5706-11.
PMID: 19960568
Aim: To analyze the correlation between preexisting comorbidity and other clinicopathological features, short-term surgical outcome and long-term survival in elderly patients with colorectal cancer (CRC). Methods: According to age, 403...
5.
Corso G, Pedrazzani C, Marrelli D, Pascale V, Pinto E, Roviello F
Arch Surg
. 2009 Aug;
144(8):722-7.
PMID: 19687375
Hypothesis: Microsatellite instability (MSI) correlates with clinicopathologic characteristics and long-term prognosis in patients having gastric carcinoma. Design: Analysis of prospectively collected data and biologic material. Setting: Tertiary University Hospital, Policlinico...
6.
Marrelli D, Pedrazzani C, Corso G, Neri A, Di Martino M, Pinto E, et al.
Ann Surg
. 2009 Jun;
250(1):43-50.
PMID: 19561483
Objective: To compare clinicopathological features and long-term outcome in gastric cancer patients coming from high-risk and low-risk areas of Italy. Summary Background Data: Better survival rates have been reported from...
7.
Marrelli D, Caruso S, Pedrazzani C, Neri A, Fernandes E, Marini M, et al.
Am J Surg
. 2009 Apr;
198(3):333-9.
PMID: 19375064
Background: Obstructive jaundice is frequently associated with false CA19-9 elevation in benign conditions. The diagnostic accuracy of this tumor marker was evaluated in the present longitudinal study. Methods: In 128...
8.
Corso G, Berardi A, Marrelli D, Pedrazzani C, Garosi L, Pinto E, et al.
Eur J Cancer Prev
. 2008 Dec;
18(1):46-9.
PMID: 19077564
The objective of this study was to find out whether C-160A single nucleotide polymorphism of the promoter region of the E-cadherin gene might be a potential genetic marker for identifying...
9.
Roviello F, Pedrazzani C, Marrelli D, Neri A, Caruso S, Rampone B, et al.
Chir Ital
. 2008 Aug;
60(3):367-79.
PMID: 18709775
Despite the decrease in incidence observed during the last decades, gastric adenocarcinoma remains the fourth most common cancer in the world and the second leading cause of cancer-related death. Radical...
10.
Roviello F, Corso G, Pedrazzani C, Marrelli D, De Falco G, Suriano G, et al.
Oncology
. 2008 Jan;
72(3-4):243-7.
PMID: 18185018
Objectives: Only 1% of diffuse gastric cancers occur in families with autosomal dominant gastric cancer susceptibility. Germline mutations in the E-cadherin gene account for the hereditary diffuse gastric cancer (HDGC)...